Qrons Inc. announced that it has filed an International Patent Application at the International Bureau, for inventions of Therapeutic Polypseudorotaxane Hydrogels. This provides Qrons with the option to, in the future, seek protection for these inventions globally. This International Patent Application was filed on March 12, 2023, and was assigned application number PCT/IB2023/052368.

It relates to uses of hydrogel compositions in the treatment of pathological central nervous system conditions such as traumatic injury or neurodegenerative disease, as well as manufacturing techniques for such compositions.